Stockhead
July 14, 2026
Island advances Galidesivir towards pivotal FDA Animal Rule trial with Texas Biomed deal
BioWorld
July 14, 2026
Island Pharma targets Ebola species lacking approved treatments
Sky News
July 13, 2026
Behind how Australian-headquartered Island Pharmaceuticals was approved to treat deadly Ebola outbreak
Kalkine
July 13, 2026
Island Pharmaceuticals Advances Galidesivir Development with Texas Biomed Collaboration
Moomoo
July 13, 2026
Island Pharmaceuticals Signs Statement of Work With Texas Biomed to Advance Galidesivir, Shares Hit Six Month High
Kalkine
July 8, 2026
Island Pharmaceuticals Advances Galidesivir for Ebola and Marburg Outbreaks
The Australian
July 7, 2026
Island Pharma gets green light to use Galidesivir in Ebola outbreak
Bloomberg
July 7, 2026
Island Pharma Jumps After Emergency Use Approval For Ebola Drug
Australian Financial Review
July 7, 2026
Australian company cleared to deploy drug in deadly Ebola outbreak
Pharma Phorum
July 7, 2026
Island Pharma drug cleared for Bundibugyo Ebola use
The Australian
July 2, 2026
Island lands Singapore patent for ISLA-101 in Dengue and Chikungunya
Kalkine
June 17, 2026
Island Pharmaceuticals (ASX:ILA) Advances Galidesivir Program with New FDA Recognition
The Australian
June 10, 2026
Island expands its US biodefence collaboration for heavy-hitting virus study
Bio Tech Dispatch
June 4, 2026
Island Pharmaceuticals begins GMP manufacture of Galidesivir to support pivotal Marburg study
The Australian
May 21, 2026
Island taps biopharmaceutical heavyweight to advance biodefence opportunity
Small Caps
May 19, 2026
Island Pharmaceuticals Strengthens Biodefence Engagement for Galidesivir Advancement
Stockhead
May 18, 2026
Health Check: Island Pharmaceuticals shares soar on spreading Ebola outbreak
The Australian
April 28, 2026